Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|October 5, 2013
Exploiting dendritic cells in the development of cancer vaccinesLaura Bracci, Imerio Capone, Federica Moschella, et al.
Seminars in Immunopathology|May 26, 2011
Immunomodulatory effects of cyclophosphamide and implementations for vaccine designAntonella Sistigu, Sophie Viaud, Nathalie Chaput, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathwayGiovanna Schiavoni, Claudia Mauri, Davide Carlei, et al.
Vaccine|July 11, 2006
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virusLaura Bracci, Irene Canini, Massimo Venditti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functionsLuigia Pace, Sara Vitale, Beatrice Dettori, et al.
International Journal of Cancer|October 5, 2017
Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamideCarla Buccione, Alessandra Fragale, Federica Polverino, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 8, 2020
Nicotinamide inhibits melanoma in vitro and in vivoFrancesca Scatozza, Federica Moschella, Daniela D'Arcangelo, et al.
Oncotarget|August 4, 2016
Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesisEleonora Aricò, Paola Sestili, Giulia Carpinelli, et al.
Cancer Research|March 30, 2011
Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamideFederica Moschella, Mara Valentini, Eleonora Aricò, et al.
Pageof 4